Recap: LivaNova Q1 Earnings


Shares of LivaNova LIVN were unchanged after the company reported Q1 results.

Quarterly Results

Earnings per share rose 6.06% year over year to $0.35, which beat the estimate of $0.15.

Revenue of $247,600,000 rose by 2.15% year over year, which beat the estimate of $232,300,000.

Looking Ahead

LivaNova hasn't issued any earnings guidance for the time being.

LivaNova hasn't issued any revenue guidance for the time being.

How To Listen To The Conference Call

Date: Apr 28, 2021

Time: 07:00 AM

ET Webcast URL:

Recent Stock Performance

Company's 52-week high was at $85.17

Company's 52-week low was at $41.07

Price action over last quarter: Up 8.06%

Company Description

U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!